Clinical Roundup Conventional age-based guidelines for CRC screening do not account for health status, life expectancy, UT Southwestern researchers find December 01, 2023Vol.49 No.44
Clinical Roundup Liver cancer rates are rising with each successive generation of Mexican Americans, study finds December 01, 2023Vol.49 No.44
Drugs & Targets FDA approves Xtandi for non-metastatic castration-sensitive prostate cancer with biochemical recurrence December 01, 2023Vol.49 No.44
Drugs & Targets FDA grants Breakthrough Therapy Designation to epcoritamab-bysp December 01, 2023Vol.49 No.44
White House As Biden invokes wartime powers to regulate AI, oncology braces for fundamental change November 17, 2023Vol.49 No.43By Matthew Bin Han Ong
Conversation with The Cancer Letter Paige’s Razik Yousfi: Biden has set expectations for AI, but details will come via federal guidelines November 17, 2023Vol.49 No.43By Matthew Bin Han Ong
White House Biden intends to appoint W. Kimryn Rathmell as NCI director November 17, 2023Vol.49 No.43By Paul Goldberg
Regulatory News ODAC reviews two longest-running accelerated approvals as FDA weighs using its new authority November 17, 2023Vol.49 No.43By Jacquelyn Cobb
ESMO discussants urge physicians to prescribe lower dose of Amgen’s sotorasib November 17, 2023Vol.49 No.43By Paul Goldberg
